Golimumab (Optimization)

( DrugBank: Golimumab / KEGG DRUG: Golimumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03182166 (ClinicalTrials.gov)	November 21, 2017	29/5/2017	Golimumabin Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimizati ...	Pharmacokinetic and Pharmacodynamic Study of Golimumabin Ulcerative Colitis (UC) Patients With Loss ...	Ulcerative Colitis	Drug: Golimumab (Optimization);Diagnostic Test: Rectosigmoidoscopy;Biological: Blood samples	Centre Hospitalier Universitaire de Saint Etienne	Merck Sharp & Dohme Corp.	Completed	18 Years	N/A	All	51	Phase 2	France

First Previous1Next Last